Usana Health Sciences (USNA) Cash from Operations (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Cash from Operations data on file, last reported at 9759000.0 in Q2 2026.

• On a quarterly basis, Cash from Operations fell 36.97% year-over-year to 9759000.0 in Q2 2026; TTM through Apr 2026 was 16626000.0, a 71.72% decrease from a year earlier, with the FY2026 full-year figure at 22349000.0, down 63.36% from the prior year.
• Cash from Operations for Q2 2026 stood at 9759000.0, up from 3390000.0 in the prior quarter.
• Over the last five years, Cash from Operations for USNA reached as high as 40463000.0 in Q4 2022 and fell as low as 3390000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 15354666.67 across 5 years, with a median of 13723000.0 in 2022.
• Across the five-year window, Cash from Operations soared 362.91% in 2022 and plunged 158.6% in 2026, its largest moves.
• Year by year, Cash from Operations stood at 40463000.0 in 2022, then sank by 35.69% to 26023000.0 in 2023, then slumped by 77.77% to 5785000.0 in 2024, then slumped by 133.9% to 1961000.0 in 2025, then surged by 597.65% to 9759000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 9759000.0 in Q2 2026, 3390000.0 in Q1 2026, and 1961000.0 in Q3 2025.